104 related articles for article (PubMed ID: 3673663)
1. Factor VII-phospholipid complex in male survivors of acute myocardial infarction.
Dalaker K; Smith P; Arnesen H; Prydz H
Acta Med Scand; 1987; 222(2):111-6. PubMed ID: 3673663
[TBL] [Abstract][Full Text] [Related]
2. A simple method for determination of the factor VII-phospholipid complex using Normotest.
Dalaker K; Janson TL; Johnsen B; Skartlien AH; Prydz H
Thromb Res; 1987 Aug; 47(3):287-93. PubMed ID: 3629556
[TBL] [Abstract][Full Text] [Related]
3. Increased activity of factor VII and factor VII-phospholipid complex measured using a Normotest system in subjects with hyperlipidemia.
Nordøy A; Illingworth DR; Connor WE; Goodnight S
Haemostasis; 1990; 20(2):65-72. PubMed ID: 2347517
[TBL] [Abstract][Full Text] [Related]
4. A novel form of factor VII in plasma from men at risk for cardiovascular disease.
Dalaker K; Hjermann I; Prydz H
Br J Haematol; 1985 Oct; 61(2):315-22. PubMed ID: 4041375
[TBL] [Abstract][Full Text] [Related]
5. Factor VII and extrinsic pathway inhibitor in acute coronary disease.
Sandset PM; Sirnes PA; Abildgaard U
Br J Haematol; 1989 Jul; 72(3):391-6. PubMed ID: 2788454
[TBL] [Abstract][Full Text] [Related]
6. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
[TBL] [Abstract][Full Text] [Related]
7. Congenital protein C deficiency and myocardial infarction:concomitant factor VII hyperactivity may play a role in the onset of arterial thrombosis.
Kario K; Matsuo T; Tai S; Sakamoto S; Yamada T; Miki T; Matsuo M
Thromb Res; 1992 Jul; 67(1):95-103. PubMed ID: 1440517
[TBL] [Abstract][Full Text] [Related]
8. Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma.
Skartlien AH; Lyberg-Beckmann S; Holme I; Hjermann I; Prydz H
Arteriosclerosis; 1989; 9(6):798-801. PubMed ID: 2686604
[TBL] [Abstract][Full Text] [Related]
9. [Coagulation factor VII levels in uremic patients and theirs influence factors].
Fang J; Xia LH; Wei WN; Song SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):730-2. PubMed ID: 15631649
[TBL] [Abstract][Full Text] [Related]
10. [Increased fibrinogen and factor VII activity levels in patients after myocardial infarction].
Mamont B; Sawicka B
Kardiol Pol; 1992 Nov; 37(11):283-6. PubMed ID: 1287288
[TBL] [Abstract][Full Text] [Related]
11. Phospholipase C-sensitive factor VIII activity in normal pregnancy.
Dalaker K; Ingebretsen OC; Rasmussen S; Nordbø Berge L; Prydz H
Acta Obstet Gynecol Scand; 1990; 69(2):111-4. PubMed ID: 2386012
[TBL] [Abstract][Full Text] [Related]
12. Plasma level of triglyceride-rich lipoprotein remnants is closely associated with the activation of coagulation factor VII in patients with myocardial infarction.
Saigo M; Abe S; Ogawa M; Biro S; Minagoe S; Maruyama I; Toda H; Kiyonaga K; Atsuchi Y; Tahara M; Mawatari K; Tei C
Thromb Res; 2000 Oct; 100(1):9-17. PubMed ID: 11053611
[TBL] [Abstract][Full Text] [Related]
13. Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarin.
Holm J; Hillarp A; Erhardt L; Berntorp E
Thromb Res; 1999 Nov; 96(3):205-12. PubMed ID: 10588463
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction.
Iacoviello L; Di Castelnuovo A; De Knijff P; D'Orazio A; Amore C; Arboretti R; Kluft C; Benedetta Donati M
N Engl J Med; 1998 Jan; 338(2):79-85. PubMed ID: 9420338
[TBL] [Abstract][Full Text] [Related]
15. Hageman factor and risk of myocardial infarction in middle-aged men.
Kelleher CC; Mitropoulos KA; Imeson J; Meade TW; Martin JC; Reeves BE; Hughes LO
Atherosclerosis; 1992 Nov; 97(1):67-73. PubMed ID: 1445495
[TBL] [Abstract][Full Text] [Related]
16. Changes in coagulation factors following acute myocardial infarction in man.
Rennie JA; Ogston D
Haemostasis; 1976; 5(4):258-64. PubMed ID: 1002008
[TBL] [Abstract][Full Text] [Related]
17. Behavior of coagulation factors and normal inhibitors of coagulation during the acute phase of myocardial infarction.
Moyssakis I; Vlahodimitris IE; Kanakis MA; Kapsimali V; Tsoucala C; Vaiopoulos GA
Blood Coagul Fibrinolysis; 2010 Oct; 21(7):670-3. PubMed ID: 20885133
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen, factor VII, antithrombin III, cholesterol and triglycerides in young men with myocardial infarction and in their sons.
Jastrzebska M; Torbus-Lisiecka B; Pieczul-Mróz J; Chełstowski K; Naruszewicz M
Mater Med Pol; 1997; 29(1-4):3-7. PubMed ID: 10214462
[TBL] [Abstract][Full Text] [Related]
19. Temporal and genotype-driven variation of factor VII levels in patients with acute myocardial infarction.
Ferraresi P; Campo G; Marchetti G; Pinotti M; Valgimigli M; Gemmati D; Ferrari R; Bernardi F
Clin Appl Thromb Hemost; 2009 Feb; 15(1):119-22. PubMed ID: 19150996
[No Abstract] [Full Text] [Related]
20. Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease.
Lindman AS; Pedersen JI; Arnesen H; Hjerkinn EM; Veierød MB; Prydz H; Seljeflot I
Thromb Res; 2004; 113(1):57-65. PubMed ID: 15081566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]